Newspaper article The Canadian Press

Deb Jorn, Who Ran Valeant's Dermatology and Gastrointestinal Businesses, Resigns

Newspaper article The Canadian Press

Deb Jorn, Who Ran Valeant's Dermatology and Gastrointestinal Businesses, Resigns

Article excerpt

Valeant executive Deb Jorn resigns

--

LAVAL, Que. - Valeant Pharmaceuticals International announced Wednesday that Deb Jorn has resigned as executive vice-president, company group chairman, effective immediately.

Jorn was responsible for running Valeant's U.S. dermatology and gastrointestinal businesses.

Eric Abramson, vice-president dermatology & immunology marketing, has been appointed general manager of the U.S. dermatology business and Dr. Ari Kellen, executive vice-president and company group chairman, will oversee Valeant's gastrointestinal business.

Valeant is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.